Dare Bioscience
DARE
35 hedge funds and large institutions have $2.04M invested in Dare Bioscience in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 4 reducing their positions, and 4 closing their positions.
175% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 4
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
17% more funds holding
Funds holding: 30 → 35 (+5)
0.66% less ownership
Funds ownership: 1.22% → 0.56% (-0.66%)
66% less capital invested
Capital invested by funds: $5.97M → $2.04M (-$3.93M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$58.3K |
| 2 |
Renaissance Technologies
New York
|
+$18.5K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$13.7K |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$11.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$8.37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$2.99M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$61.1K |
| 3 |
Jane Street
New York
|
-$11.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$10.8K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$6.36K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $1.36K | – | – | – |
|
27
Osaic Holdings
Scottsdale,
Arizona
| $618 | -$1.6K | -350 | -68% |
|
28
Wells Fargo
San Francisco,
California
| $234 | +$46 | +10 | +19% |
|
|
LPP
29
Life Planning Partners
Jacksonville,
Florida
| $119 | +$146 | +32 | New |
|
30
Morgan Stanley
New York
| $90 | -$900 | -197 | -89% |
|
31
Bank of America
Charlotte,
North Carolina
| $85 | +$105 | +23 | New |
|
|
CSC
32
Caldwell Sutter Capital
Sausalito,
California
| $62 | – | – | – |
|
|
CPG
33
Cornerstone Planning Group
Fairfield,
New Jersey
| $5 | – | – | – |
|
|
NA
34
NewEdge Advisors
New Orleans,
Louisiana
| $3 | +$5 | +1 | New |
|
|
AC
35
Armistice Capital
New York
| – | -$2.99M | -539,167 | Closed |
|
|
36
Citadel Advisors
Miami,
Florida
| – | -$61.1K | -11,032 | Closed |
|
|
37
Jane Street
New York
| – | -$11.5K | -2,084 | Closed |
|
|
TSS
38
Two Sigma Securities
New York
| – | -$10.8K | -1,956 | Closed |
|
39
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$206 | +45 | New |
|
DARE Hedge Fund Activity: Q4 2023 in Review
35 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q4 2023, worth a combined $2.04M — down 66% from $5.97M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new DARE positions and 4 closed out — a net gain of 6 holders — while 11 added to existing stakes and 4 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $58.3K. The largest seller was Armistice Capital, exiting entirely with an estimated $2.99M sold.
- 35 institutional investors held Dare Bioscience (DARE) as of Q4 2023, up from 30 in Q3 2023.
- Funds reported $2.04M of Dare Bioscience stock for Q4 2023, down 66% quarter-over-quarter.
- 10 funds opened new Dare Bioscience positions in Q4 2023 and 4 closed out, a net change of +6 holders.
- The largest Dare Bioscience buyer in Q4 2023 was Geode Capital Management, an estimated $58.3K added.
- The largest Dare Bioscience seller in Q4 2023 was Armistice Capital, an estimated $2.99M sold.
Based on aggregated 13F filings for Q4 2023.